Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Imperiale

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
Medical Physics|September 18, 2023
A radiomic- and dosiomic-based machine learning regression model for pretreatment planning in <sup>177</sup> Lu-DOTATATE therapyDimitris Plachouris, Vassilios Eleftheriadis, Thomas Nanos, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 15, 2025
Normal organ [<sup>68</sup>Ga]DOTATOC uptake during PRRT: challenging the assumption of stable background shaped by cold somatostatin analogues treatmentHind Ait Talhiq, Philippe Baltzinger, Juliette Frega, et al.
Metabolites|December 15, 2019
Metabolomics of Small Intestine Neuroendocrine Tumors and Related Hepatic MetastasesAlessio Imperiale, Gilles Poncet, Pietro Addeo, et al.
Cancers|December 24, 2021
Liver-Directed Therapy for Neuroendocrine Metastases: From Interventional Radiology to Nuclear Medicine ProceduresRoberto Luigi Cazzato, Fabrice Hubelé, Pierre De Marini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2019
Early <sup>18</sup>F-FDOPA PET/CT imaging after carbidopa premedication as a valuable diagnostic option in patients with insulinomaBenjamin Leroy-Freschini, Vincent Amodru, Pietro Addeo, et al.
Cancers|July 2, 2021
Involvement of Neutrophils in Metastatic Evolution of Pancreatic Neuroendocrine TumorsVéronique Debien, Guillaume Davidson, Philippe Baltzinger, et al.
Endocrine|December 23, 2024
Organ-specific response to [<sup>177</sup>Lu]DOTATATE peptide receptor radionuclide therapy (PRRT) assessed by sequential [<sup>68</sup>Ga]DOTATOC PET/CT in patients with metastatic small intestine neuroendocrine tumorsDarejan Mamulashvili Bessac, Philippe Baltzinger, Nathan Poterszman, et al.
Journal of Nuclear Medicine Technology|March 17, 2026
Radiomics on <sup>177</sup>Lu-DOTATATE Posttreatment Scans: Feasibility, Preprocessing Optimization, and Planar-SPECT ComparisonFlavio Montanini, Alessio Imperiale, Alice Monaci, et al.
Langenbeck'S Archives of Surgery|February 24, 2017
Implications of SDHB genetic testing in patients with sporadic pheochromocytomaAurelie Maignan, Carole Guerin, Valentin Julliard, et al.
Endocrine-Related Cancer|March 27, 2015
Carney triad, SDH-deficient tumors, and Sdhb+/- mice share abnormal mitochondriaEva Szarek, Evan R Ball, Alessio Imperiale, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Medical Physics|September 18, 2023
A radiomic- and dosiomic-based machine learning regression model for pretreatment planning in <sup>177</sup> Lu-DOTATATE therapyDimitris Plachouris, Vassilios Eleftheriadis, Thomas Nanos, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 15, 2025
Normal organ [<sup>68</sup>Ga]DOTATOC uptake during PRRT: challenging the assumption of stable background shaped by cold somatostatin analogues treatmentHind Ait Talhiq, Philippe Baltzinger, Juliette Frega, et al.
Metabolites|December 15, 2019
Metabolomics of Small Intestine Neuroendocrine Tumors and Related Hepatic MetastasesAlessio Imperiale, Gilles Poncet, Pietro Addeo, et al.
Cancers|December 24, 2021
Liver-Directed Therapy for Neuroendocrine Metastases: From Interventional Radiology to Nuclear Medicine ProceduresRoberto Luigi Cazzato, Fabrice Hubelé, Pierre De Marini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2019
Early <sup>18</sup>F-FDOPA PET/CT imaging after carbidopa premedication as a valuable diagnostic option in patients with insulinomaBenjamin Leroy-Freschini, Vincent Amodru, Pietro Addeo, et al.
Cancers|July 2, 2021
Involvement of Neutrophils in Metastatic Evolution of Pancreatic Neuroendocrine TumorsVéronique Debien, Guillaume Davidson, Philippe Baltzinger, et al.
Endocrine|December 23, 2024
Organ-specific response to [<sup>177</sup>Lu]DOTATATE peptide receptor radionuclide therapy (PRRT) assessed by sequential [<sup>68</sup>Ga]DOTATOC PET/CT in patients with metastatic small intestine neuroendocrine tumorsDarejan Mamulashvili Bessac, Philippe Baltzinger, Nathan Poterszman, et al.
Journal of Nuclear Medicine Technology|March 17, 2026
Radiomics on <sup>177</sup>Lu-DOTATATE Posttreatment Scans: Feasibility, Preprocessing Optimization, and Planar-SPECT ComparisonFlavio Montanini, Alessio Imperiale, Alice Monaci, et al.
Langenbeck'S Archives of Surgery|February 24, 2017
Implications of SDHB genetic testing in patients with sporadic pheochromocytomaAurelie Maignan, Carole Guerin, Valentin Julliard, et al.
Endocrine-Related Cancer|March 27, 2015
Carney triad, SDH-deficient tumors, and Sdhb+/- mice share abnormal mitochondriaEva Szarek, Evan R Ball, Alessio Imperiale, et al.
Pageof 14